Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1996;74(2):121–129.

HIV and AIDS: where is the epidemic going?

T E Mertens 1, D Low-Beer 1
PMCID: PMC2486902  PMID: 8706227

Abstract

Routine surveillance of HIV (human immunodeficiency virus) infection and AIDS has been established over the past decade in many countries around the world. HIV estimates derived from empirical data are essential to the assessment of the HIV situation in different parts of the world and trends are used in tracking the development of regional epidemics, thereby keeping intervention activities focused on realities. As of the end of 1995, and following an extensive country-by-country review of HIV/AIDS data, a cumulative total of 6 million AIDS cases were estimated to have occurred in adults and children worldwide and currently 20.1 million adults are estimated to be alive and infected with HIV or have AIDS. Of the total prevalent HIV infections, the majority remain concentrated in eastern, central and southern Africa, but the epidemic is evolving with spread of infection from urban to rural areas, as well as to West and South Africa, India and South-east Asia, and to a lesser extent--with proportional shifts to heterosexual infections--in North America, western Europe and Latin America. While the longer-term dimensions of the HIV epidemic at global level cannot be forecast with confidence, WHO currently projects a cumulative total of close to 40 million HIV infections in men, women and children by the year 2000. By that time, the male:female ratio of new infections will be close to 1:1. Recent trends indicate that HIV prevalence levels may be stabilizing or even decreasing among pregnant women in southern Zaire and parts of Uganda, among military recruits aged 21 in Thailand, and in some populations of northern Europe and the USA. While these changes may take place as part of the intrinsic dynamic of the epidemic, there is some evidence that declines in HIV prevalence are related to declines in HIV incidence which are, at least partly, due to prevention efforts. The challenge of surveillance and evaluation methods is now to identify the ingredients of success which may reveal a glimmer of hope.

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baggaley R., Godfrey-Faussett P., Msiska R., Chilangwa D., Chitu E., Porter J., Kelly M. Impact of HIV infection on Zambian businesses. BMJ. 1994 Dec 10;309(6968):1549–1550. doi: 10.1136/bmj.309.6968.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chin J., Lwanga S. K. Estimation and projection of adult AIDS cases: a simple epidemiological model. Bull World Health Organ. 1991;69(4):399–406. [PMC free article] [PubMed] [Google Scholar]
  3. Dunn D. T., Newell M. L., Ades A. E., Peckham C. S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992 Sep 5;340(8819):585–588. doi: 10.1016/0140-6736(92)92115-v. [DOI] [PubMed] [Google Scholar]
  4. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. doi: 10.1016/s0140-6736(95)91380-7. [DOI] [PubMed] [Google Scholar]
  5. Jacquez J. A., Koopman J. S., Simon C. P., Longini I. M., Jr Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr. 1994 Nov;7(11):1169–1184. [PubMed] [Google Scholar]
  6. Kitayaporn D., Uneklabh C., Weniger B. G., Lohsomboon P., Kaewkungwal J., Morgan W. M., Uneklabh T. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS. 1994 Oct;8(10):1443–1450. doi: 10.1097/00002030-199410000-00011. [DOI] [PubMed] [Google Scholar]
  7. Mertens T. E., Belsey E., Stoneburner R. L., Beer D. L., Sato P., Burton A., Merson M. H. Global estimates and epidemiology of HIV-1 infections and AIDS: further heterogeneity in spread and impact. AIDS. 1995;9 (Suppl A):S259–S272. [PubMed] [Google Scholar]
  8. Mertens T., Caraël M., Sato P., Cleland J., Ward H., Smith G. D. Prevention indicators for evaluating the progress of national AIDS programmes. AIDS. 1994 Oct;8(10):1359–1369. doi: 10.1097/00002030-199410000-00002. [DOI] [PubMed] [Google Scholar]
  9. Mulder D. W., Nunn A. J., Kamali A., Nakiyingi J., Wagner H. U., Kengeya-Kayondo J. F. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet. 1994 Apr 23;343(8904):1021–1023. doi: 10.1016/s0140-6736(94)90133-3. [DOI] [PubMed] [Google Scholar]
  10. Selik R. M., Chu S. Y., Buehler J. W. HIV infection as leading cause of death among young adults in US cities and states. JAMA. 1993 Jun 16;269(23):2991–2994. [PubMed] [Google Scholar]
  11. Van de Perre P., Meda N. Interventions to reduce mother to child transmission of HIV. AIDS. 1995;9 (Suppl A):S59–S66. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES